These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36566619)

  • 1. Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies.
    Basdavanos A; Maurer MS; Ives L; Derwin K; Ricchetti ET; Seitz W; Hanna M
    Am J Cardiol; 2023 Mar; 190():67-74. PubMed ID: 36566619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?
    Rubin J; Alvarez J; Teruya S; Castano A; Lehman RA; Weidenbaum M; Geller JA; Helmke S; Maurer MS
    Amyloid; 2017 Dec; 24(4):226-230. PubMed ID: 28906148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.
    Palmer C; Truong VT; Slivnick JA; Wolking S; Coleman P; Mazur W; Zareba KM
    Sci Rep; 2022 Jan; 12(1):140. PubMed ID: 34996915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
    Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA
    Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis.
    Enríquez-Vázquez D; Gómez-Martín C; Barge-Caballero G; Barge-Caballero E; López-Pérez M; Bilbao-Quesada R; González-Babarro E; Gómez-Otero I; López-López A; Gutiérrez-Feijoo M; Varela-Román A; Crespo-Leiro MG
    Med Clin (Barc); 2024 Apr; 162(7):e1-e7. PubMed ID: 38423944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.
    Porcari A; Rossi M; Cappelli F; Canepa M; Musumeci B; Cipriani A; Tini G; Barbati G; Varrà GG; Morelli C; Fumagalli C; Zampieri M; Argirò A; Vianello PF; Sessarego E; Russo D; Sinigiani G; De Michieli L; Di Bella G; Autore C; Perfetto F; Rapezzi C; Sinagra G; Merlo M
    Eur J Heart Fail; 2022 Jul; 24(7):1227-1236. PubMed ID: 35509181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
    López-Sainz Á; Hernandez-Hernandez A; Gonzalez-Lopez E; Domínguez F; Restrepo-Cordoba MA; Cobo-Marcos M; Gómez-Bueno M; Hernandez-Perez FJ; Oteo JF; Mirelis JG; Cavero MA; Moñivas V; Mingo Santos S; de Haro-Del Moral FJ; Krsnik I; Salas C; Bornstein B; Briceño A; López JA; Vázquez J; Alonso-Pulpón L; Segovia J; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):149-158. PubMed ID: 32317158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Amyloidosis Treatment.
    Stern LK; Patel J
    Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors.
    Barge-Caballero G; Vázquez-García R; Barge-Caballero E; Couto-Mallón D; Paniagua-Martín MJ; Barriales-Villa R; Piñón-Esteban P; Bouzas-Mosquera A; Pombo-Otero J; Debén-Ariznavarreta G; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Med Clin (Barc); 2021 Apr; 156(8):369-378. PubMed ID: 32591181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
    Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
    Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcalcification and
    Mori A; Saito Y; Nakamura K; Iida T; Akagi S; Yoshida M; Taniyama M; Miyoshi T; Ito H
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
    Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
    Donnellan E; Wazni OM; Hanna M; Elshazly MB; Puri R; Saliba W; Kanj M; Vakamudi S; Patel DR; Baranowski B; Cantillon D; Dresing T; Jaber WA
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1118-1127. PubMed ID: 32972546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 17. United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
    Griffin JM; Chiu L; Axsom KM; Bijou R; Clerkin KJ; Colombo P; Cuomo MO; De Los Santos J; Fried JA; Goldsmith J; Habal M; Haythe J; Helmke S; Horn EM; Latif F; Hi Lee S; Lin EF; Naka Y; Raikhelkar J; Restaino S; Sayer GT; Takayama H; Takeda K; Teruya S; Topkara V; Tsai EJ; Uriel N; Yuzefpolskaya M; Farr MA; Maurer MS
    Clin Transplant; 2020 Oct; 34(10):e14028. PubMed ID: 32623785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography.
    Itzhaki Ben Zadok O; Eisen A; Shapira Y; Monakier D; Iakobishvili Z; Schwartzenberg S; Abelow A; Ofek H; Kazum S; Ben-Avraham B; Hamdan A; Bental T; Sagie A; Kornowski R; Vaturi M
    Am J Cardiol; 2020 Oct; 133():126-133. PubMed ID: 32811652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years.
    Ioannou A; Patel RK; Razvi Y; Porcari A; Sinagra G; Venneri L; Bandera F; Masi A; Williams GE; O'Beara S; Ganesananthan S; Massa P; Knight D; Martinez-Naharro A; Kotecha T; Chacko L; Brown J; Rauf MU; Manisty C; Moon J; Lachmann H; Wechelakar A; Petrie A; Whelan C; Hawkins PN; Gillmore JD; Fontana M
    Circulation; 2022 Nov; 146(22):1657-1670. PubMed ID: 36325894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
    Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
    Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.